4
Changes in Ownership
TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-21-009646
Exec. VP Chief Legal Officer sold 65,312 shares at $12.69 ($829,103)
- Exec. VP Chief Legal Officer acquired 52,774 shares (grant or award)
- Exec. VP Chief Legal Officer acquired 12,538 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Stark David Matthew · Exec. VP Chief Legal Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-02-09 | Exercise or conversion : show line 1 in the form | +12,538 | 15,512.39 | D | ||
| 2021-02-09 | Grant or award : show line 2 in the form | +52,774 | 68,286.39 | D | ||
| 2021-02-09 | Sale : show line 3 in the form | −12,538 | $12.69 | $159,164 | 55,748.39 | D |
| 2021-02-09 | Sale : show line 4 in the form | −52,774 | $12.69 | $669,940 | 2,974.39 | D |
| Open-market sales · 65,312 sh · avg $12.69 · $829,103 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-02-09 | Exercise or conversion : show line 5 in the form Restricted Share Units | −12,538 | 12,538 | D |
| 2021-02-09 | Grant or award : show line 6 in the form Restricted Share Units | +37,884 | 37,884 | D |
Loading xslF345X03/doc4.xml…